International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2021 - Volume 25, Number 2
View All Articles in Issue

Page(s): 145

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, levodopa, carbidopa, parkinsonian syndrome, parkinsonism, decarboxylase inhibitor, stability

Related Categories: EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2021 Pg. 145
Levodopa and Carbidopa Rectal Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 149
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2002 Pg. 202
Carbidopa 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 70
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Lisinopril 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 318
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 491
Topiramate 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 138
Baclofen 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 224
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 315
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2019 Pg. 234
Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 508
Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 417
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4 Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C	Jul/Aug 2020 Pg. 327-336
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 55
Dipyridamole 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2019 Pg. 408
Return to Top